Today: Meet the 2026
Endpoints 11

Monday, Sept. 28 | 11 a.m. - 1 p.m. ET | Virtual

Eleven private biotechs cleared the bar this year. Thursday we named them. Today we go deeper.

In exclusive sit-down interviews, four honorees walk through the science, the story behind their company and how they got here:

• Denitsa Milanova, CEO, Medici Therapeutics
• Michelle Lee, CEO, Medra
• Weihao Xu, CEO, Kali Therapeutics
• Andrei Georgescu, CEO, Vivodyne

Plus a fireside chat with Don Ingber of Harvard's Wyss Institute, highlights from the gala and conversations with the Endpoints editors on why these companies made the list. It's free to register. 

SPONSORED BY

COMMUNITY PARTNERS